Gotham Asset Management’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Gotham Asset Management’s Portfolio RPTP Stock Details RPTP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-16,756	Closed	-$150K	–	1145
2016 Q3	$150K	Buy	+16,756	New	+$119K	﹤0.01%	881
2015 Q3	–	Sell	-18,396	Closed	-$290K	–	1139
2015 Q2	$290K	Buy	+18,396	New	+$223K	﹤0.01%	823
2014 Q4	–	Sell	-22,595	Closed	-$217K	–	1165
2014 Q3	$217K	Buy	+22,595	New	+$231K	﹤0.01%	910

Gotham Asset Management's RPTP Position: Q4 2016 in Review

Gotham Asset Management sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q4 2016, closing a stake of 16,756 shares — an estimated $150K sold.

Gotham Asset Management first reported a position in RPTP in Q3 2014 and held it in 3 quarters. The position peaked at $290K in Q2 2015. 0 funds tracked by Wall St. Rank hold RPTP as of Q4 2016.

Gotham Asset Management reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q4 2016 after selling out during the quarter.
Gotham Asset Management sold 16,756 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q4 2016, an estimated $150K.
Gotham Asset Management first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q3 2014 and held it in 3 quarters.
Gotham Asset Management's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $290K in Q2 2015.
0 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q4 2016.

Based on Gotham Asset Management's 13F filing for Q4 2016, filed 14 Feb 2017.